Author details

Full Name

Joanne Kamens

Affiliation

ORCID

Career Start Year

1990

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
33257865	Sample sharing.	Nature Biotechnology	2020
31849618	Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation.	Front Neuroanat	2019
30102688	Provenance and risk in transfer of biological materials.	PLoS Biol	2018
28748929	Open data: enforce materials sharing.	Nature	2017
28946923	Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic.	Genome Med	2017
26585970	Accelerating research through reagent repositories: the genome editing example.	Genome Biol	2015
25392412	The Addgene repository: an international nonprofit plasmid and data resource.	Nucleic Acids Research	2015
26057981	Career coaching for scientists.	Nature Biotechnology	2015
26348966	MASS AWIS: Supporting women in science for over a decade.	Nature Biotechnology	2015
25387006	Addgene: making materials sharing "science as usual".	PLoS Biology	2014
23051805	Assessing unintended hybridization-induced biological effects of oligonucleotides.	Nature Biotechnology	2012
21493786	Potent and systematic RNAi mediated silencing with single oligonucleotide compounds.	RNA	2011
19926477	2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimization.	Bioorganic and Medicinal Chemistry Letters	2010
20167638	Modified dsRNAs that are not processed by Dicer maintain potency and are incorporated into the RISC.	Nucleic Acids Research	2010
16652449	Mass uprising of women in science.	Nature	2006
16087150	Purification and kinetic characterization of recombinant human mitogen-activated protein kinase kinase kinase COT and the complexes with its cellular partner NF-kappa B1 p105.	Archives of Biochemistry and Biophysics	2005
15190265	cis-Element clustering correlates with dose-dependent pro- and antisignaling effects of IL18.	Genes Immun	2004
15342401	SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.	Cancer Res	2004
12771142	Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck.	J Biol Chem	2003
12444544	Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.	Oncogene	2002
11297557	Direct phosphorylation of NF-kappaB1 p105 by the IkappaB kinase complex on serine 927 is essential for signal-induced p105 proteolysis.	Journal of Biological Chemistry	2001
11717807	Lck inhibitors as a therapeutic approach to autoimmune disease and transplant rejection.	Current Opinion in Investigational Drugs	2001
11301322	PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells.	J Biol Chem	2001
11012021	Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck I.	Bioorganic and Medicinal Chemistry Letters	2000
9115214	Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.	Journal of Biological Chemistry	1997
7797510	Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases.	Journal of Biological Chemistry	1995
1768648	A yeast transcription assay defines distinct rel and dorsal DNA recognition sequences.		1991
2111443	Oncogenic transformation by vrel requires an amino-terminal activation domain.	Molecular and Cellular Biology	1990